InsidersTradesSigma
Total declarations
Company
▲ Purchases (10 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by ANDREEFF DANE. Director active across 1 companies, notably Helius Medical Technologies, INC.. Aggregated, 12 disclosures have been published. Total volume traded: €665k. The latest transaction was disclosed on 17 December 2021 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations12 total
€5,9091,275 shares@ €4.63450.0047% mcap1.8% of flow
Class A Common Stock
SEC:0001209191-21-070723·
Ideal exit: 13 Sept 2022 (T+270)
€5,9091,275 shares@ €4.63450.0047% mcap0.9% of flow
Class A Common Stock
SEC:0001209191-21-070723:0·
Ideal exit: 13 Sept 2022 (T+270)
€160,40822,960 shares@ €6.98640.13% mcap48.3% of flow
Common Stock
SEC:0001209191-21-064379·
Ideal exit: 9 Aug 2022 (T+270)
€160,40822,960 shares@ €6.98640.13% mcap24.1% of flow
Common Stock
SEC:0001209191-21-064379:0·
Ideal exit: 9 Aug 2022 (T+270)
€67,3585,408 shares@ €12.45530.053% mcap20.3% of flow
Common Stock
SEC:0001209191-21-056384·
Ideal exit: 12 Jun 2022 (T+270)
€67,3585,408 shares@ €12.45530.053% mcap10.1% of flow
Common Stock
SEC:0001209191-21-056384:0·
Ideal exit: 12 Jun 2022 (T+270)
€68,4255,408 shares@ €12.65260.054% mcap20.6% of flow
Common Stock
SEC:0001209191-21-055662·
Ideal exit: 7 Jun 2022 (T+270)
€68,4255,408 shares@ €12.65260.054% mcap10.3% of flow
Common Stock
SEC:0001209191-21-055662:0·
Ideal exit: 7 Jun 2022 (T+270)
€30,2062,407 shares@ €12.54930.024% mcap9.1% of flow
Common Stock
SEC:0001209191-21-055275·
Ideal exit: 4 Jun 2022 (T+270)
€30,2062,407 shares@ €12.54930.024% mcap4.5% of flow
Common Stock
SEC:0001209191-21-055275:0·
Ideal exit: 4 Jun 2022 (T+270)
0937 shares0
Class A Common Stock
SEC:0001209191-21-036233·
0937 shares0
Class A Common Stock
SEC:0001209191-21-036233:0·
12 of 12 declarations
About ANDREEFF DANE
Dane Andreeff is a director at Helius Medical Technologies, INC.
